Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Journal of Cardiac Failure|December 1, 2009
Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trialPeter Carson, S William Tam, Jalal K Ghali, et al.
Journal of Cardiac Failure|July 26, 2002
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodologyJoseph A Franciosa, Anne L Taylor, Jay N Cohn, et al.
Journal of the American College of Cardiology|September 19, 2006
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT TrialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 29, 2007
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure TrialJalal K Ghali, S William Tam, Keith C Ferdinand, et al.
Congestive Heart Failure (Greenwich, Conn.)|June 9, 2006
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFTJay N Cohn, Peter E Carson, Christopher O'Connor, et al.
Circulation|August 19, 2007
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failureRoberto Latini, Serge Masson, Inder S Anand, et al.
Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.
Pageof 14